{
  "disease_name": "Hepatocellular Carcinoma",
  "synonyms": [
    "HCC",
    "Primary liver cancer"
  ],
  "summary": "Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults and is currently the most common cause of death in people with cirrhosis. It is the third leading cause of cancer-related deaths worldwide.",
  "causes": [
    "Chronic liver disease",
    "Cirrhosis",
    "Fibrosis",
    "Hepatitis B infection",
    "Hepatitis C infection",
    "Hepatitis D infection",
    "Nonalcoholic steatohepatitis (NASH)",
    "Alcoholic liver disease",
    "Aflatoxin exposure",
    "Pyrrolizidine alkaloids exposure",
    "Hemochromatosis",
    "Alpha 1-antitrypsin deficiency",
    "Wilson's disease (controversial)",
    "Biliary atresia",
    "Infantile cholestasis",
    "Glycogen-storage diseases",
    "Epigenetic alterations",
    "Mutations affecting cellular machinery",
    "Integration of HBV genome into hepatocytes' TERT promoter site",
    "Mutations in ABCB11 gene"
  ],
  "risk_factors": [
    "Chronic liver disease",
    "Cirrhosis",
    "Hepatitis B infection",
    "Hepatitis C infection",
    "Alcohol use disorder",
    "Aflatoxin",
    "Iron overload (hemochromatosis)",
    "Nonalcoholic steatohepatitis (NASH)",
    "Nonalcoholic fatty liver disease",
    "Type 2 diabetes",
    "Obesity",
    "Alpha 1-antitrypsin deficiency",
    "Hemophilia (due to coincident chronic viral hepatitis infection)",
    "Hepatocellular adenoma",
    "Î²-catenin activation mutation in hepatic adenoma",
    "Congenital liver disorders",
    "Anabolic steroid abuse (theorized)",
    "Male sex"
  ],
  "symptoms": [
    "Abdominal pain",
    "Nausea",
    "Vomiting",
    "Feeling tired",
    "Jaundice",
    "Abdominal swelling (ascites)",
    "Easy bruising",
    "Loss of appetite",
    "Unintentional weight loss"
  ],
  "diagnosis": [
    "Blood testing",
    "Imaging evaluation (ultrasound, CT scan, MRI)",
    "Biopsy (historically required, now often not needed if imaging is conclusive)",
    "Alpha-fetoprotein (AFP) blood levels",
    "Des-gamma carboxyprothrombin levels",
    "Liver image reporting and data system (LI-RADS)"
  ],
  "treatments": [
    "Surgical resection (partial hepatectomy)",
    "Orthotopic liver transplantation",
    "Radiofrequency ablation (RFA)",
    "Cryoablation",
    "Percutaneous ethanol injection",
    "Transcatheter arterial chemoembolization (TACE)",
    "Selective internal radiation therapy (SIRT)",
    "Proton therapy",
    "Sorafenib",
    "Lenvatinib",
    "Regorafenib",
    "Cabozantinib",
    "Ramucirumab",
    "Atezolizumab",
    "Bevacizumab",
    "Tremelimumab",
    "Durvalumab",
    "Portal vein embolization (PVE)",
    "High intensity focused ultrasound (HIFU)",
    "Mipsagargin (G-202) (preclinical/investigational)",
    "JX-594 (oncolytic virus, investigational)",
    "Hepcortespenlisimut-L (Hepko-V5) (oral cancer vaccine, investigational)"
  ],
  "related_genes": [
    "TERT promoter",
    "TP53",
    "CTNNB1",
    "AXIN1",
    "ARID1A",
    "ARID2",
    "ABCB11"
  ],
  "subtypes": [
    "Fibrolamellar variant of hepatocellular carcinoma",
    "Fibrolamellar",
    "Pseudoglandular (adenoid)",
    "Pleomorphic (giant cell)",
    "Clear cell",
    "Lymphoepithelioma like hepatocellular carcinoma"
  ]
}